Anika Therapeutics, Inc. (ANIK)
USD 16.04
(-3.49%)
USD 16.04
(-3.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 29.03 Million USD | -6.0% |
| 2022 | 30.89 Million USD | 60.55% |
| 2021 | 19.24 Million USD | -7.85% |
| 2020 | 20.87 Million USD | -2.28% |
| 2019 | 21.36 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 9.6 Million USD | -14.29% |
| 2011 | 11.2 Million USD | -12.5% |
| 2010 | 12.8 Million USD | -11.11% |
| 2009 | 14.4 Million USD | 800.0% |
| 2008 | 1.6 Million USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 1 Million USD | 0.0% |
| 1994 | 1 Million USD | 0.0% |
| 1993 | 1 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 28.07 Million USD | -1.39% |
| 2024 Q1 | 28.47 Million USD | -1.94% |
| 2024 Q3 | 2.29 Million USD | -1.93% |
| 2023 Q2 | 29.86 Million USD | -1.73% |
| 2023 Q1 | 30.38 Million USD | -1.63% |
| 2023 FY | 29.03 Million USD | -6.0% |
| 2023 Q4 | 29.03 Million USD | 6.55% |
| 2023 Q3 | 27.25 Million USD | -8.73% |
| 2022 FY | 30.89 Million USD | 60.55% |
| 2022 Q4 | 30.89 Million USD | -0.69% |
| 2022 Q2 | 31.6 Million USD | 54.4% |
| 2022 Q1 | 20.47 Million USD | 6.39% |
| 2022 Q3 | 31.1 Million USD | -1.59% |
| 2021 Q4 | 19.24 Million USD | -9.16% |
| 2021 FY | 19.24 Million USD | -7.85% |
| 2021 Q1 | 22.17 Million USD | 6.23% |
| 2021 Q2 | 21.6 Million USD | -2.59% |
| 2021 Q3 | 21.18 Million USD | -1.96% |
| 2020 Q1 | 21.73 Million USD | 1.7% |
| 2020 Q2 | 71.41 Million USD | 228.63% |
| 2020 Q3 | 47.75 Million USD | -33.13% |
| 2020 Q4 | 20.87 Million USD | -56.28% |
| 2020 FY | 20.87 Million USD | -2.28% |
| 2019 Q2 | 21.97 Million USD | -1.16% |
| 2019 Q1 | 22.23 Million USD | 0.0% |
| 2019 Q4 | 21.36 Million USD | -1.09% |
| 2019 Q3 | 21.6 Million USD | -1.69% |
| 2019 FY | 21.36 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | 9.2 Million USD | -4.17% |
| 2013 Q4 | - USD | -100.0% |
| 2013 Q3 | 8.4 Million USD | -4.55% |
| 2013 Q2 | 8.8 Million USD | -4.35% |
| 2013 FY | - USD | -100.0% |
| 2012 FY | 9.6 Million USD | -14.29% |
| 2012 Q2 | 10.4 Million USD | -3.7% |
| 2012 Q4 | 9.6 Million USD | -4.0% |
| 2012 Q3 | 10 Million USD | -3.85% |
| 2012 Q1 | 10.8 Million USD | -3.57% |
| 2011 FY | 11.2 Million USD | -12.5% |
| 2011 Q4 | 11.2 Million USD | -3.45% |
| 2011 Q3 | 11.6 Million USD | -3.33% |
| 2011 Q2 | 12 Million USD | -3.23% |
| 2011 Q1 | 12.4 Million USD | -3.13% |
| 2010 FY | 12.8 Million USD | -11.11% |
| 2010 Q2 | 13.6 Million USD | -2.86% |
| 2010 Q3 | 13.2 Million USD | -2.94% |
| 2010 Q1 | 14 Million USD | -2.78% |
| 2010 Q4 | 12.8 Million USD | -3.03% |
| 2009 Q3 | 14.8 Million USD | -2.63% |
| 2009 FY | 14.4 Million USD | 800.0% |
| 2009 Q2 | 15.2 Million USD | -2.56% |
| 2009 Q1 | 15.6 Million USD | 875.0% |
| 2009 Q4 | 14.4 Million USD | -2.7% |
| 2008 Q3 | 8 Million USD | 0.0% |
| 2008 Q4 | 1.6 Million USD | -80.0% |
| 2008 FY | 1.6 Million USD | 0.0% |
| 2008 Q1 | 4 Million USD | 0.0% |
| 2008 Q2 | 8 Million USD | 100.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | 29.18 Million USD | 0.0% |
| 2001 Q4 | - USD | -100.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1996 Q1 | 1 Million USD | 0.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q3 | 1 Million USD | 0.0% |
| 1995 Q4 | 1 Million USD | 0.0% |
| 1995 Q1 | 1 Million USD | 0.0% |
| 1995 Q2 | 1 Million USD | 0.0% |
| 1995 FY | 1 Million USD | 0.0% |
| 1994 FY | 1 Million USD | 0.0% |
| 1994 Q1 | 1 Million USD | 0.0% |
| 1994 Q3 | 1 Million USD | 0.0% |
| 1994 Q4 | 1 Million USD | 0.0% |
| 1994 Q2 | 1 Million USD | 0.0% |
| 1993 FY | 1 Million USD | 0.0% |
| 1993 Q3 | 1 Million USD | 11.11% |
| 1993 Q2 | 900 Thousand USD | 0.0% |
| 1993 Q4 | 1 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 541.67 Million USD | 94.639% |
| Nemaura Medical Inc. | 20.03 Million USD | -44.966% |
| NeuroPace, Inc. | 72.39 Million USD | 59.891% |
| LENSAR, Inc. | 2.3 Million USD | -1157.557% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -295.276% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -1720.502% |
| Apyx Medical Corporation | 38.5 Million USD | 24.581% |
| Cutera, Inc. | 431.91 Million USD | 93.277% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -85.742% |
| BioSig Technologies, Inc. | 452 Thousand USD | -6324.115% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 25.964% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 98.273% |
| Axonics, Inc. | 27.61 Million USD | -5.142% |
| IRIDEX Corporation | 2.74 Million USD | -957.429% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 63.339% |
| TELA Bio, Inc. | 42.78 Million USD | 32.125% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -7769.106% |
| RxSight, Inc. | 3.01 Million USD | -864.044% |
| Align Technology, Inc. | 96.96 Million USD | 70.055% |
| INVO Bioscience, Inc. | 8.68 Million USD | -234.39% |
| electroCore, Inc. | 626 Thousand USD | -4538.498% |
| Telesis Bio, Inc. | 34.38 Million USD | 15.541% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -182.704% |
| Quipt Home Medical Corp. | 98.94 Million USD | 70.653% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1136.67% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -90.344% |
| Dynatronics Corporation | 6.68 Million USD | -334.169% |
| Modular Medical, Inc. | 1.19 Million USD | -2340.084% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -10982.824% |
| Talis Biomedical Corporation | 19.66 Million USD | -47.636% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -2027.19% |
| InMode Ltd. | 9.01 Million USD | -222.025% |
| Envoy Medical, Inc. | 404 Thousand USD | -7087.376% |
| Bruker Corporation | 1.37 Billion USD | 97.895% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -50842.105% |
| DexCom, Inc. | 2.59 Billion USD | 98.881% |
| Nexalin Technology, Inc. | 4463.00 USD | -650516.177% |
| PAVmed Inc | 48.72 Million USD | 40.406% |
| Viveve Medical, Inc. | 5.34 Million USD | -442.849% |
| Cerus Corporation | 95.99 Million USD | 69.753% |
| Movano Inc. | 252 Thousand USD | -11422.619% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 12.471% |
| Nexalin Technology, Inc. | 4463.00 USD | -650516.177% |
| IceCure Medical Ltd | 599 Thousand USD | -4747.579% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 93.014% |
| enVVeno Medical Corporation | 1.4 Million USD | -1971.113% |
| 908 Devices Inc. | 5.94 Million USD | -388.427% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -108.285% |
| Orthofix Medical Inc. | 134.19 Million USD | 78.363% |
| Surmodics, Inc. | 29.4 Million USD | 1.251% |
| Nuwellis, Inc. | 981 Thousand USD | -2859.939% |
| Outset Medical, Inc. | 136.18 Million USD | 78.679% |
| Venus Concept Inc. | 79.69 Million USD | 63.566% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 77.634% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 58.697% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -245.843% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -2988.004% |
| Inogen, Inc. | 21.92 Million USD | -32.45% |
| IRadimed Corporation | 2.04 Million USD | -1321.262% |
| MaxCyte, Inc. | 18.74 Million USD | -54.922% |
| Pulmonx Corporation | 41.42 Million USD | 29.903% |
| PAVmed Inc. | 48.72 Million USD | 40.406% |
| iCAD, Inc. | 461 Thousand USD | -6198.698% |
| OrthoPediatrics Corp. | 23.76 Million USD | -22.21% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -1354.395% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -5801.937% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -15646.746% |
| SI-BONE, Inc. | 38.99 Million USD | 25.531% |
| Semler Scientific, Inc. | 70 Thousand USD | -41381.429% |
| Beyond Air, Inc. | 17.83 Million USD | -62.791% |
| FONAR Corporation | 41.67 Million USD | 30.327% |
| AxoGen, Inc. | 69.29 Million USD | 58.095% |
| Biotricity, Inc. | 23.87 Million USD | -21.602% |
| Cytosorbents Corporation | 18.31 Million USD | -58.558% |
| ZimVie Inc. | 521.92 Million USD | 94.437% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 42.358% |
| Inari Medical, Inc. | 32.04 Million USD | 9.392% |
| UFP Technologies, Inc. | 46.03 Million USD | 36.927% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -1354.395% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -845.504% |
| Sight Sciences, Inc. | 35.41 Million USD | 18.007% |
| Insulet Corporation | 1.44 Billion USD | 97.996% |
| Profound Medical Corp. | 7.9 Million USD | -267.54% |
| Bioventus Inc. | 409.47 Million USD | 92.909% |
| InspireMD, Inc. | 1.59 Million USD | -1720.502% |
| BrainsWay Ltd. | 471 Thousand USD | -6064.968% |
| BIOLASE, Inc. | 17.91 Million USD | -62.127% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -2701.885% |
| Tenon Medical, Inc. | 1.17 Million USD | -2375.448% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -2797.904% |
| CVRx, Inc. | 30.61 Million USD | 5.148% |
| AdaptHealth Corp. | 2.29 Billion USD | 98.735% |
| Sintx Technologies, Inc. | 4.24 Million USD | -584.028% |
| Acutus Medical, Inc. | 38.47 Million USD | 24.538% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -1355.489% |
| NanoVibronix, Inc. | 5000.00 USD | -580640.0% |
| Quanterix Corporation | 41.46 Million USD | 29.971% |
| LivaNova PLC | 640.4 Million USD | 95.466% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -870.953% |
| Varex Imaging Corporation | 469.5 Million USD | 93.815% |
| Vivani Medical, Inc. | 20.69 Million USD | -40.302% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -1136.67% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -3608.429% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 96.891% |
| TransMedics Group, Inc. | 515.94 Million USD | 94.372% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -1425.854% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -11954.75% |
| Spectral AI, Inc. | 1.28 Million USD | -2152.676% |
| Hyperfine, Inc. | 185 Thousand USD | -15595.676% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 84.894% |
| Biomerica, Inc. | 785 Thousand USD | -3598.981% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -6360.089% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -7745.611% |
| Silk Road Medical, Inc | 84.63 Million USD | 65.691% |